Future growth expectations in sales/revenue/volumes?

The company expects to sustain double-digit top-line revenue growth in FY '26 and beyond. Personal Care segment has shown consistent double-digit growth over the last 6-7 quarters, driven by category expansion and market leadership. Digital channel (e-commerce) now contributes about 10%-11% of revenue and growing faster than other segments. Food & Nutrition segment growth is improving, although some sizable brands like Complan show lower growth; initiatives underway to improve this. New product launches like protein chips and cookies under Max Protein are positively building momentum.

Future growth expectations in earnings/operating earnings/profits/EPS?

Management expects to sustain double-digit top-line growth in FY '26 and beyond. EBITDA growth is projected to be in sync with or faster than top-line growth. Gross margins have been improving steadily over 6-7 quarters and are expected to continue rising, supported by pricing power, cost efficiencies, and inflation management. Operating margins are on an improving trajectory, with management confident that the improvement journey is not yet complete. Synergies from the Ritebite acquisition are expected to drive margin expansion, with the business anticipated to be EPS accretive by FY '26. Def

IN US

Sale is live|00:00:00left today

Zydus Wellness LtdQ4 FY26Food Products

Zydus Wellness Ltd Q4 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹534P/E: 66.5Market Cap: ₹16.0K CrSector: Food Products

Management growth scorecard

Revenue

Category 3

Margin

Category 2

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

→The company expects to sustain double-digit top-line revenue growth in FY '26 and beyond.
→Personal Care segment has shown consistent double-digit growth over the last 6-7 quarters, driven by category expansion and market leadership.
→Digital channel (e-commerce) now contributes about 10%-11% of revenue and growing faster than other segments.
→Food & Nutrition segment growth is improving, although some sizable brands like Complan show lower growth; initiatives underway to improve this.
→New product launches like protein chips and cookies under Max Protein are positively building momentum.
→Management remains focused on driving growth ahead of the industry, targeting better performance and improving profitability.
→Innovations, digital marketing, AI, and data analytics are key to capturing consumer insights and sales efficiency for future growth.
→Market shifts towards organized trade and quick commerce are secular trends supporting sustained growth.

Margin guidance

Category 2

→Management expects to sustain double-digit top-line growth in FY '26 and beyond.
→EBITDA growth is projected to be in sync with or faster than top-line growth.
→Gross margins have been improving steadily over 6-7 quarters and are expected to continue rising, supported by pricing power, cost efficiencies, and inflation management.
→Operating margins are on an improving trajectory, with management confident that the improvement journey is not yet complete.
→Synergies from the Ritebite acquisition are expected to drive margin expansion, with the business anticipated to be EPS accretive by FY '26.
→Deferred tax liabilities impact net profit but operating profit improvements and reduction in debt are expected to boost margins.
→Focus on cost control, product mix optimization, and expanding organized trade channels is expected to enhance profitability.
→Management anticipates EBITDA margins potentially rising to 17%-18% in the coming 6-8 quarters.

3 more insights locked — sign up free to unlock

Fundraise plans

Based on the information on pages 1-21 of the provided document from Zydus Wellness Limited (February 04, 2025): - There is no explicit mention of any current or planned new fundraising through equity or debt in the latest call transcript. - Management discusses improving profitability and reducing debt over the coming years but does not specify any new debt issuance. - The focus is on operational growth, margin improvement, and bolt-on acquisitions financed prudently. - No direct commentary on raising capital through equity or fresh debt is provided in the Q&A or closing remarks. - The company is emphasizing organic growth, margin expansion, and strategic acquisitions rather than capital raising. Hence, no clear indication of imminent or planned fundraising through debt or equity as per the latest update.

Order book

The transcript for Zydus Wellness Limited’s Q3 FY2025 earnings call does not provide specific details about the current or expected order book or pending orders. However, relevant insights related to business performance and outlook include: - Strong focus on double-digit growth in revenue and EBITDA. - Confidence in sustaining growth momentum with new product launches and expansion in digital channels. - Anticipation of revival in demand, especially in urban areas, supported by government measures in Budget 2025. - Continued emphasis on innovation and consumer engagement, especially in categories like nutrition bars and protein products. - Executives discussed growth strategies but did not disclose specific order book or pending order volumes. No quantitative or qualitative disclosure on order backlog or pending orders is mentioned in the available transcript.

Capex plans

Yes

The transcript and report excerpts do not explicitly mention any specific current or future capital expenditure (capex) or strategic capital investments by Zydus Wellness Limited. However, some relevant points include: - Focus on category development and brand extension (e.g., extending Nutralite into cheese, mayonnaise; Sugar Free into chocolates and cookies) which may imply marketing or product development investments. - Acquisitions have been described as "bolt-ons" to fill portfolio gaps, with Ritebite acquisition expected to be EPS accretive by FY '26. - Investments in digital and AI capabilities for improved consumer engagement and sales force efficiency. - Advertising investments increased post-2021-23 to support growth, expected not to accelerate at the same past pace. - No specific capex amounts, timelines, or strategic investment projects were disclosed in the available transcript. Overall, no direct details on capex were provided, but strategic investments focus on brand extensions, acquisitions, and digital/AI initiatives.

How does Zydus Wellness Ltd rank vs peers in Food Products?

Pro feature

1Zydus Wellness Ltd

Rev 3Mar 2

See full Food Products sector rankings

Want more stocks like Zydus Wellness Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio